Status:
UNKNOWN
The Impact of Polynuclear Neutrophils' Intra-tumoral Rate and the Mutational Status in Pulmonary Adenocarcinomas on Survival
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Pulmonary Adenocarcinoma
Eligibility:
All Genders
Brief Summary
Lung cancer is one of the most frequent cancer concerning human beings and it represents, worldwide, one of the first cause of death. Most of patients with this cancer are males and 85% of lung cancer...
Eligibility Criteria
Inclusion
- Patients with stages I to III lung adenocarcinoma (TNM UICC 8ème édition)
- Patients who went through a first surgery with a lymph node dissection at the CHRU of Nancy between 01/01/2010 and 01/01/2012
- Patients included in the CRB CHRU-INSERM bronchial collection
Exclusion
- patients who received neoadjuvant therapy.
- Stage IV patients (TNM UICC 8ème édition)
- Patients whose surgical resection was incomplete
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04761640
Start Date
February 1 2021
End Date
September 1 2021
Last Update
February 21 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.